Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Michail A Belyavskyi

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox (-138 properties)
Infobox
Patent primary examiner of
‌
US Patent 11168303 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
‌
US Patent 11168304 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
‌
US Patent 7235632 Isolated mammalian protein present at the surface of all lymphoid progenitor cells and all mature NK cells and uses thereof
‌
US Patent 7285397 Insect poison allergens with reduced IgE reactivity and method producing the same
‌
US Patent 11180729 Compositions and methods including cytotoxic B lymphocyte cell line expressing exogenous membrane immunoglobulin different from secreted immunoglobulin
‌
US Patent 7364733 Antibody to receptor on the surface of activated T-cells: ACT-4
‌
US Patent 7399632 Mesenchymal precursor cell
‌
US Patent 7399836 Method of manufacturing a carrier having immobilized antibodies
‌
US Patent 7402431 T-cell therapy formulation
‌
US Patent 7404954 Methods of targeting agents to cells expressing the polymeric immunoglobulin receptor
‌
US Patent 7408039 Kits for treatment of hematologic disorders
‌
US Patent 7416726 Enhancement of antibody-mediated immune responses
‌
US Patent 7419670 Method of treating arthritis with SERP-1 and an immunosuppressant
‌
US Patent 7425331 Protein A methods of use
‌
US Patent 7425607 Compositions comprising a lung tumor antigen
‌
US Patent 7429383 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
‌
US Patent 7429489 Methods of controlling proliferation and differentiation of stem and progenitor cells
‌
US Patent 7432065 Methods of identifying modulators of interaction between PDZ domain proteins and PL proteins
‌
US Patent 7435592 Compositions for allogeneic cell therapy
‌
US Patent 7449555 Antibodies of angiogenesis inhibiting domains CD148
‌
US Patent 7455836 Method of treatment and agents useful for same
‌
US Patent 7465788 Breast cancer resistance protein (BCRP) and antibodies thereto
‌
US Patent 7473425 Remedies for ischemic disease
‌
US Patent 7476540 Monoclonal antibodies to mesenchymal stem cells
‌
US Patent 7479371 Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor
‌
US Patent 7482436 Human antihuman interleukin-6 antibody and fragment of antibody
‌
US Patent 7485314 Induction of antigen specific immunologic tolerance
‌
US Patent 7488480 Use of passive myostatin immunization in egg laying vertebrates
‌
US Patent 7491392 Antibodies to human IL-1β
‌
US Patent 7498023 Blockade of T cell migration into epithelial GVHD target tissues as an approach to achieving anti-tumor effects against lymphohematopoietic malignancies without GVHD
‌
US Patent 7504482 Recombinant soluble Fc receptors
‌
US Patent 7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors
‌
US Patent 7514224 Arrays of PDZ domain polypeptides
‌
US Patent 7514229 Methods for diagnosing and evaluating treatment of blood disorders
‌
US Patent 11186819 Methods of serum-free culturing corneal limbal stromal stem cells and inducing sphere formation and differentiation in vitro
‌
US Patent 11186827 Genetically modified stem cells
‌
US Patent 7517957 Human SLAP-2: a novel SH2/ SH3 domain-containing human SLAP homologue having immune cell-specific expression
‌
US Patent 7524500 Method of stimulating stem cells
‌
US Patent 7524502 Modified anti-TNF alpha antibody
‌
US Patent 7524937 WSX receptor agonist antibodies
‌
US Patent 7524939 Antibodies that bind to and inhibit human cytochrome P450 2C9*1, 2C9*2, and 2C9*3
‌
US Patent 7528240 Method for producing human anti-thymocyte immunoglobulins
‌
US Patent 7541443 Anti-CD4 antibodies
‌
US Patent 7544359 Remedies for ischemic disease
‌
US Patent 7556803 Method for treating multiple myeloma
‌
US Patent 7557194 Antibody materials for an IBD-associated polypeptide
‌
US Patent 7563459 Methods and compositions for regenerating tissue
‌
US Patent 7572897 Antibodies against insulin-like growth factor I receptor and uses thereof
‌
US Patent 7576186 Compositions and methods for stem cell delivery
‌
US Patent 7579157 Antibody selection method against IGF-IR
‌
US Patent 7582313 Methods of organ regeneration using
‌
US Patent 7585504 High affinity antibodies against HMGB1 and methods of use thereof
‌
US Patent 7585954 Antibodies for diagnosing psoriasis
‌
US Patent 7592431 Biodegradable T-cell Activation device
‌
US Patent 7597906 Apoptosis-mimicking synthetic entities and use thereof in medical treatment
‌
US Patent 7618629 Manipulation of cytokine levels using CD83 gene products
‌
US Patent 7618654 Mammalian myeloid progenitor cell subsets
‌
US Patent 7622557 Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (BCRP)
‌
US Patent 7628988 Methods and compositions for treating type 1 diabetes
‌
US Patent 7632505 Treatment of macrophage mediated disease
‌
US Patent 7635477 Parathyroid hormone receptor activation and stem and progenitor cell expansion
‌
US Patent 7638121 Methods for human allografting
‌
US Patent 7638285 Method of the discrimination and isolation of mammary epithelial stem and colony-forming cells
‌
US Patent 7638606 Antibodies that bind interleukin-4 receptor
‌
US Patent 7651678 Methods to impair hematologic cancer progenitor cells and compounds related thereto
‌
US Patent 7655225 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
‌
US Patent 7658921 Molecules with extended half-lives, compositions and uses thereof
‌
US Patent 7670600 Molecules with extended half-lives, compositions and uses thereof
‌
US Patent 7670628 Mesenchymal precursor cell
‌
US Patent 7670788 Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides
‌
US Patent 7678572 Methods for preparing T-cells for cell therapy
‌
US Patent 7691415 Method for preventing, or reducing the severity of, graft-versus-host disease using pluri-differentiated mesenchymal progenitor cells
‌
US Patent 7691587 Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides
‌
US Patent 7695933 SM38 nucleic acid molecules
‌
US Patent 7700316 CD109 nucleic acid molecules, polypeptides and methods of use
‌
US Patent 7700740 Antibodies to CD83
‌
US Patent 7704497 Molecules with extended half-lives, compositions and uses thereof
‌
US Patent 7705117 EGFH2 genes and gene products
‌
US Patent 7709256 Disease model incorporation into an artificial immune system (AIS)
‌
US Patent 7718196 Rapamycin-resistant T cells and therapeutic uses thereof
‌
US Patent 7718379 Identifying haematopoietic stem cells based on cell surface markers
‌
US Patent 7723047 Method for the discrimination and isolation of mammary epithelial stem and colony-forming cells
‌
US Patent 7727527 Anti-NGF antibodies for the therapeutic treatments
‌
US Patent 7731969 Methods for developing and producing antigen-specific antibody-producing cells
‌
US Patent 7740854 Treatment of macrophage mediated disease
‌
US Patent 7744927 Methods of promoting hematopoietic and mesenchymal cell proliferation and differentiation
‌
US Patent 7771999 Disease model incorporation into an artificial immune system (AIS)
‌
US Patent 7776334 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
‌
US Patent 7776591 Hematopoietic stem cells treated by in vitro fucosylation and methods of use
‌
US Patent 7785883 Automatable artificial immune system (AIS)
‌
US Patent 7790157 Methods of modulating CARK protein activity
‌
US Patent 7790453 Smooth muscle progenitor cells
‌
US Patent 7790454 Method for tissue regeneration
‌
US Patent 7794756 Methods of using antibodies to VEGF-C
‌
US Patent 7799349 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
‌
US Patent 7799350 Use of cytokines and mitogens to inhibit graft versus host disease
‌
US Patent 7803910 Soluble CD164 polypeptides
‌
US Patent 7803917 Breast cancer resistance protein (BCRP) and antibodies thereto
‌
US Patent 7807170 Protein A compositions and methods of use
‌
US Patent 7811816 Isolated CD8
‌
US Patent 7815921 Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy
‌
US Patent 7816088 Identification, isolation and elimination of cancer stem cells
‌
US Patent 7816134 Method of extensive culture of antigen-specific cytotoxic T cells
‌
US Patent 7816135 Method of analyzing lymphocytes
‌
US Patent 7834157 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
‌
US Patent 7838041 Method for treating multiple myeloma
‌
US Patent 7842501 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
‌
US Patent 7846434 Materials and methods for improved immunoglycoproteins
‌
US Patent 7846724 Method for selecting CHO cell for production of glycosylated antibodies
‌
US Patent 7850968 Manipulation of cytokine levels using CD83 gene products
‌
US Patent 7851219 Methods and compositions for increasing protein yield from a cell culture
‌
US Patent 7855074 Artificial immune system: methods for making and use
‌
US Patent 7855075 Methods of controlling proliferation and differentiation of stem and progenitor cells
‌
US Patent 7855268 Tolerogizing compositions comprising botulinum toxin type B peptides
‌
US Patent 7858094 TREM-1 splice variant for use in modifying immune responses
‌
US Patent 7863043 Stem cell populations and methods of use
‌
US Patent 7872103 Modulating immune responses
‌
US Patent 7875703 LIR-9, a novel leukocyte immunoglobulin-like receptor
‌
US Patent 7879799 Methods for characterizing glycoproteins and generating antibodies for same
‌
US Patent 7879982 19.5 polypeptide antibodies useful for diagnosing or treating psoriasis
‌
US Patent 7883701 Method for enhancing growth or increasing feed efficiency through reducing binding between endotoxin and its receptor in the gastrointestinal tract
‌
US Patent 7892548 121P1F1: a tissue specific protein highly expressed in various cancers
‌
US Patent 7892578 Treatment of hematologic disorders
‌
US Patent 7892828 Method of identifying a MHC class I restricted T cell response
‌
US Patent 7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors
‌
US Patent 7906331 Methods for identifying stem cells expressing breast cancer resistance protein (BCRP)
‌
US Patent 7910368 Method of extended culture for antigen-specific cytotoxic lymphocytes
‌
US Patent 7915043 CD34(+) cells and their methods of use
‌
US Patent 7919315 In vitro method for the diagnosis of cardiovascular functionality of bone marrow precursor cells (BMPS) and/or blood-derived circulating precursor cells (BDPS)
‌
US Patent 7932361 Antibodies to HT5GJ57
‌
US Patent 7939062 Methods for human allografting
‌
US Patent 7943136 Parathyroid hormone receptor activation and stem and progenitor cell expansion
‌
US Patent 7947266 Perivascular mesenchymal precursor cells
‌
US Patent 7956164 Device for enhancing immunostimulatory capabilities of T-cells
‌
US Patent 7960531 EG-VEGF nucleic acids and polypeptides and methods of use
‌
US Patent 7964406 Means and methods for producing a stabilized cell of interest
‌
US Patent 7998481 Modulation of NKG2D for treating or preventing solid organ allograft rejection
‌
US Patent 8008076 Method of producing a nucleic acid encoding an antibody
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8008076 Method of producing a nucleic acid encoding an antibody
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7998481 Modulation of NKG2D for treating or preventing solid organ allograft rejection
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7964406 Means and methods for producing a stabilized cell of interest
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7960531 EG-VEGF nucleic acids and polypeptides and methods of use
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7956164 Device for enhancing immunostimulatory capabilities of T-cells
Edits on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7947266 Perivascular mesenchymal precursor cells
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7943136 Parathyroid hormone receptor activation and stem and progenitor cell expansion
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7939062 Methods for human allografting
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7932361 Antibodies to HT5GJ57
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7915043 CD34(+) cells and their methods of use
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7910368 Method of extended culture for antigen-specific cytotoxic lymphocytes
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7906331 Methods for identifying stem cells expressing breast cancer resistance protein (BCRP)
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7892828 Method of identifying a MHC class I restricted T cell response
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7892578 Treatment of hematologic disorders
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7892548 121P1F1: a tissue specific protein highly expressed in various cancers
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7879982 19.5 polypeptide antibodies useful for diagnosing or treating psoriasis

Find more people like Michail A Belyavskyi

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo